Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-02-01

FDA Approved: COSOPT PF — Original Application (Thea Pharma Inc.)

View source ↗

Summary

FDA approved Cosopt PF (dorzolamide hydrochloride and timolol maleate) under an original application from Thea Pharma Inc. for reducing elevated intraocular pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COSOPT PF (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)

Snippet

ORIG AP for COSOPT PF (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)